Log In
BCIQ
Print this Print this
 

ALM AADx

  Manage Alerts
Collapse Summary General Information
Company Almac Group Ltd.
Description63-gene expression signature assay
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify a subgroup of patients with high-grade serous ovarian cancer with a better prognosis for survival following standard chemotherapy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today